tiprankstipranks
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market
Holding BLTE?
Track your performance easily

Belite Bio, Inc. ADR (BLTE) Income Statement

26 Followers

Belite Bio, Inc. ADR Income Statement

Last quarter (Q4 2023), Belite Bio, Inc. ADR's total revenue was $―, a decrease of ― from previous quarter. In Q4, Belite Bio, Inc. ADR's net income was $―. See Belite Bio, Inc. ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
---$ 0.00$ 0.00
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
-$ 31.67M$ -12.82M$ 9.80M$ 5.74M
Operating Income
-$ -31.67M$ -12.82M$ -9.80M$ -5.74M
Net Non Operating Interest Income Expense
-$ 49.00K$ 7.00K$ 5.00K$ -9.00K
Other Income Expense
-$ 4.00K$ -166.00K$ 126.00K-
Pretax Income
-$ -31.62M$ -12.65M$ -9.67M$ -5.75M
Tax Provision
-$ 9.00K-$ 0.00$ 1.00K
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
-$ -31.63M$ -12.65M$ -9.67M$ -5.75M
Basic EPS
-$ -1.19$ -0.63$ -0.40$ -0.24
Diluted EPS
-$ -1.19$ -0.63$ -0.40$ -0.24
Basic Average Shares
-$ 26.59M$ 19.98M$ 24.10M$ 24.10M
Diluted Average Shares
-$ 26.59M$ 19.98M$ 24.10M$ 24.10M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
-$ 31.67M$ -12.82M$ 9.80M$ 5.74M
Net Income From Continuing And Discontinued Operation
-$ -31.63M$ -12.65M$ -9.67M$ -5.75M
Normalized Income
---$ -9.67M$ -5.75M
Interest Expense
---$ 0.00$ 21.00K
EBIT
--$ -12.63M$ -9.67M$ -5.73M
EBITDA
--$ -12.43M$ -9.64M$ -5.71M
Currency in USD

Belite Bio, Inc. ADR Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis